Vaccine
(Vaccine) 《疫苗》
2015年影响因子
3.413
期刊介绍
《疫苗》杂志是爱德华·詹纳学会、国际疫苗学会和日本疫苗学会的官方刊物。主要接受以下方面的投稿:人用疫苗-感染性疾病,人用疫苗-非感染性疾病,兽用疫苗,免疫学与动物模型,载体、佐剂和投药系统,生产与制造,疫苗安全性,监管、社会及法规事项,疫苗学历史。
展开
推荐阅读
- 2013-11-27•2004~2009年中国季节性流感疫苗供应与目标预防接种人群
- 2012-10-16•一种可改善抗手足口病毒疫苗性能的替代传送系统
- 2012-10-16•一种麻疹,流行性腮腺炎,风疹和水痘活疫苗(ProQuad®) 在≥9月婴儿中2剂接种方案的免疫原性和安全性
- 2012-10-16•狒狒中Gal-lectin亚单位疫苗抗实验性痢疾阿米巴感染和结肠炎的疗效
- 2012-10-16•麻疹病毒血球凝集素充足球状头部作为抗麻疹疫苗亚单位
- 2012-10-16•18-49岁成人中 Arbor 株减毒活流感疫苗安全性上市后评价
目录导读
Published 2012年10月,Volume 30,Issue 47
最新一期
Page CO2
Show preview | PDF (655 K) | Related articles | Related reference work articles
|
Editorial
|
Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineeringPages 6609-6611 Tewodros Mamo, Gregory A. Poland
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Meeting report
|
Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011Pages 6612-6622 Bethan Hughes, Frederick Hayden, Yuri Perikov, Joachim Hombach, John S. Tam
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Brief reports
|
Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in ChinaPages 6623-6627 Liping Shen, Fuzhen Wang, Feng Wang, Fuqiang Cui, Shuang Zhang, Hui Zheng, Yong Zhang, Xiaofeng Liang, Shengli Bi
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
|
HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: A pilot studyPages 6628-6631 David M. Phelan, Gregory A. Poland
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Regular papers
|
Estimated size of the population at risk of severe adverse events after smallpox vaccination in IsraelOriginal Research ArticlePages 6632-6635 Yael Levy, Emilia Anis, Ehud Kaliner, Itamar Grotto, Yehuda L. Danon
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
|
Safety of Zostavax™—A cohort study in a managed care organizationOriginal Research ArticlePages 6636-6641 Roger Baxter, Trung Nam Tran, John Hansen, Michael Emery, Bruce Fireman, Joan Bartlett, Ned Lewis, Patricia Saddier
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► This was an analysis of safety of the zoster vaccine. ► Risk-interval cohort study. ► 29,000 persons who received the zoster vaccine in 2006 and 2007. ► No clear increase in events was observed in the risk period after vaccination compared to later. ► People received zoster vaccine when their health was optimal, which led to confounding.
|
A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challengeOriginal Research ArticlePages 6642-6648 Qingwei Liu, Kexia Yan, Yanfang Feng, Xulin Huang, Zhiqiang Ku, Yicun Cai, Fei Liu, Jinping Shi, Zhong Huang
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► Virus-like particle (VLP) of coxsackievirus A16 was successfully produced. ► VLP immunization potently elicited neutralizing antibodies in mice. ► Passive transfer of anti-VLP sera protected mice against CVA16 lethal infection.
|
Effect of the vaccination scheme on PregSure®BVD induced alloreactivity and the incidence ofBovine Neonatal PancytopeniaOriginal Research ArticlePages 6649-6655 Rahel Kasonta, Carola Sauter-Louis, Mark Holsteg, Karin Duchow, Klaus Cussler, Max Bastian
Show preview |
Supplementary content| Related articles | Related reference work articles |
Purchase $31.50
|
Highlights
► Regional differences in the incidence of Bovine Neonatal Pancytopenia (BNP) are identified. ► The differences correlate with variations in the BVD-vaccination regimen. ► The causal correlation is confirmed by experimental immunization.
|
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of ageOriginal Research ArticlePages 6656-6664 Gustavo H. Dayan, Joan Bevilacqua, Dorothy Coleman, Aileen Buldo, George Risi
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► ChimeriVax-WN02 is a live attenuated vaccine for protection against West Nile virus. ► We assessed the immunogenicity and safety of ChimeriVax-WN02 in subjects aged ≥50. ► Subjects were randomized in 3 groups to receive 1 dose of a different formulation. ► Seroconversion was achieved at day 28 by >92% of subjects in each of the groups. ► ChimeriVax-WN02 was well tolerated in subjects in all groups.
|
Probing the protective effects of a conformationally constrained nicotine vaccineOriginal Research ArticlePages 6665-6670 Amira Y. Moreno, Marc R. Azar, George F. Koob, Kim D. Janda
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► Constrained and unconstrained nicotine haptens generate differential immune responses. ► Vaccination of constrained hapten CNI with ALUM showed protective effects in rats. ► High antibody concentration was found to be crucial in conferring protective effects. ► Nicotine analgesia is a rapid assay to probe vaccination effects.
|
Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditionsOriginal Research ArticlePages 6671-6677 Hwi Won Seo, Kiwon Han, Yeonsu Oh, Changhoon Park, Chanhee Chae
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► Chimeric PCV1-2 vaccine seems to be very effective in controlling PCV2 infection. ► Vaccinated animals displayed an improved ADG and a reduced time to market. ► Vaccination induced strong neutralizing antibodies and PCV2-specific IFN-r-SC. ► Vaccination can elicit PCV2-specific NA and IFN-γ-SC even in the presence of MDA.
|
Protective immunity against tick infestation in cattle vaccinated with recombinant trypsin inhibitor of Rhipicephalus microplusOriginal Research ArticlePages 6678-6685 Renato Andreotti, Rodrigo Casquero Cunha, Mariana Aparecida Soares, Felix D. Guerrero, Fábio P. Leivas Leite, Adalberto A. Pérez de León
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► Tested vaccine with recombinant Kunitz protein for cattle tick immunoprotection. ► Larval R. microplus trypsin inhibitor was produced in yeast expression system. ► Immunization afforded 32% efficacy against cattle tick infestation. ► Larval R. microplustrypsin inhibitor resembles three-headed Kunitz protein BmTI-6.
|
Seroprevalence of seven high-risk HPV types in The NetherlandsOriginal Research ArticlePages 6686-6693 Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp, Hein J. Boot, Hester E. de Melker, Chris J.L.M. Meijer, Guy A.M. Berbers, Fiona R.M. van der Klis
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► Pre-HPV vaccine antibody levels serve as baseline to evaluate long-term HPV vaccination effects. ► The increase in HPV seroprevalence in adolescents correlates with sexual debut, mainly for HPV16 in women. ► 10% of the population was found seropositive for multiple HPV serotypes. ► Ethnicity, marital status, casual partnership or having a STD increased the risk of HPV seropositivity.
|
No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experimentOriginal Research ArticlePages 6694-6699 Najaaraq Lund, Andreas Andersen, Ivan Monteiro, Peter Aaby, Christine Stabell Benn
Show preview |
Supplementary content| Related articles | Related reference work articles |
Purchase $31.50
|
Highlights
► This study did not support that OPV0 is associated with increased mortality in boys. ► If anything, mortality tended to be higher in infants who did not receive OPV0. ► OPV administered with BCG may lead to a dampened immune response to BCG.
|
Distinguishing vaccine efficacy and effectivenessOriginal Research ArticlePages 6700-6705 Eunha Shim, Alison P. Galvani
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
Highlights
► There are two mechanisms of vaccine action, ‘all-or-nothing’ and ‘leaky’ vaccines. ► Typical estimation of ‘leaky’ vaccine efficacy has been incorrect in mathematical models. ► We demonstrate how the common measures of vaccine can be correctly estimated.
|
Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis developmentOriginal Research ArticlePages 6706-6712 Jennifer L. Peters, Paul L. DeMars, Lindsay M. Collins, Julie A. Stoner, Hiroyuki Matsumoto, Naoka Komori, Anil Singh, Christa L. Feasley, James A. Haddock, Martin Levine
Show preview |
Supplementary content| Related articles | Related reference work articles |
Purchase $31.50
|
Highlights
► Lysine is required to maintain an epithelial barrier to bacteria in gingival sulci. ► Lysine decarboxylase from Eikenella corrodensdepletes lysine from gingival sulci. ► Antibodies to lysine decarboxylase slow lysine depletion and gingivitis progression. ► Lysine decarboxylase vaccination may retard canine periodontal disease progression.
|
US Military contributions to the global response to pandemic chikungunyaOriginal Research ArticlePages 6713-6720 Charles H. Hoke Jr., Judy Pace-Templeton, Phillip Pittman, Frank J. Malinoski, Paul Gibbs, Tracy Ulderich, Michelle Mathers, Beverly Fogtman, Pamela Glass, David W. Vaughn
Show preview | Related articles | Related reference work articles
|
Purchase $31.50
|
|
Waning population immunity to measles in TaiwanOriginal Research ArticlePages 6721-6727 Chih-Jung Chen, Ping-Ing Lee, Yu-Chia Hsieh, Po-Yen Chen, Yu-Huai Ho, Chee-Jen Chang, Ding-Ping Liu, Feng-Yee Chang, Cheng-Hsun Chiu, Yhu-Chering Huang, Chin-Yun Lee, Tzou-Yien Lin
Show preview |
Supplementary content| Related articles | Related reference work articles |
Purchase $31.50
|
Highlights
► The coverage rate of measles vaccine was >95% for more than a decade in Taiwan. ► We estimated the seroprevalence of measles in Taiwan using volunteer-based samples. ► There was a significant declining trend of seropositivity with age in vaccinees. ► The overall seroprevalence of measles was not sufficient for herd immunity. ► Waning vaccine-induced immunity weakened the population immunity to measles.
Book review
|
H. Bazin, ,Vaccination: A History. From Lady Montagu to Genetic Engineering (2011) John Libbey Eurotext,UK.Page 6728 Andrew W. Artenstein
Show preview | Related articles | Related reference work articles
|
发表评论网友评论(0)